Efficacy of thymectomy in patients diagnosed with thymomatous and nonthymomatous myasthenia gravis.
DOI:
https://doi.org/10.55204/scc.v1i1.e4Keywords:
Myasthenia Gravis, Thymoma, ThymectomyAbstract
Introduction: Myasthenia Gravis (MG) is considered an autoimmune disease, presenting antibodies that act against acetylcholine receptors causing an insufficiency in neuromuscular transmission and is manifested by a weakness or fatigue of skeletal muscles, it has been related to pathology of the thymus gland being observed as well as alterations of this organ such as Hyperplasia and Thymoma. Within the surgical treatment, Thymectomy is indicated in patients with Thymoma, which consists in the total removal of the thymus with the perithymic fat. General Objective: To analyze the efficacy of Thymectomy in patients diagnosed with Thymomatous and Non-Thymomatous Myasthenia Gravis by means of a Systematic Review. Methodology: A Systematic Review was carried out, being of a Descriptive-Analytical type, based on the consultation of bibliographic material. Results: The articles reviewed indicate that thymectomy provides good results in the treatment of thymomatous and non-thymomatous MG, patient remission may vary according to factors such as age, the time between surgery and postoperative assessment and the length of time since diagnosis of the disease.
Downloads
References
Cortés S, Cortés P, Bedoya M, Terrón R, Innerarity Martínez Jaime. Fast onset Myasthenia Gravis. Rev Clin Med Fam [Internet]. 2021 [citado 2021 Jun 29];14(1): 28-30. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699695X2021000100028&lng=es
Serrano J, Arriola J. Tratamiento quirúrgico en Miastenia Gravis.Revista medicagt [Internet]. 2021 [citado 2021 Jun 29]; 160(1). Disponible en: https://www.revistamedicagt.org/index.php/RevMedGuatemala/article/view/278
Morís G. Miastenia Gravis y trastornos relacionados con la unión neuromuscular. Rev. Medicine [Internet] 2019 [Citado 26 Ene 2020]; 12 (76): 4469-4477: Disponible en: https://sci-hub.se/https://doi.org/10.1016/j.med.2019.04.001#
Milanés Armengol A. R., Molina Castellanos K., Pino Mas J., Milanés Molina M., Ojeda Leal Á. M. Una Mirada Actual a la Miastenia Gravis. Medisur [Internet]. 2020 [Citado 12 Abr 2021]; 18(5) 907-918. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1727-897X2020000500907&script=sci_arttext&tlng=pt
Pinos-Velez N., Congregado M. Mejoras en la Caidad de Vida de los Pacientes con Miastenia Gravis sin Timoma Intervenidos con Timectomia Videotoracoscópica. Rev. Maskana. [Internet] 2019 [Citado 20 Abr 2021]: 10(1): 27-33. Disponible en: https://publicaciones.ucuenca.edu.ec/ojs/index.php/maskana/article/view/2695/1772
Castro S; Caparó C; Meza M. Actualización en Miastenia gravis.. Revista de NeuroPsiquiatría [Internet]. 2017 [citado 13-04-2021]; 80 (4) : 247-260. Disponible en: https://www.redalyc.org/articulo.oa?id=372053959004
Alqarni F, Almalki D, Aljohani Z, Ali A, AlSaleem A, Alotaibi N,et al. Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy. Rev. Neurosciences (Riyadh). [Internet] 2021 [Citado 20 Abr 2021]; 26(1): 4-14. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33530037/#:~:text=Risk%20factors%20for%20recur rence%20include,gravis%20experience%20recurrence%20after%20thymectomy.
Buitrago Ramirez M.R. Mantilla Gavira H. J., Cerreño Dueñas J. A. Tumores del Timo: Experiencia del Instituto Nacional de Cancerología de Colombia. Rev. Colombiana de Cancerología. [Internet]. 2019 [Citado 15 Abr 2021]; 23(3): 92-98. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-90152019000300092&lang=es
Popperud T., Gul K., Brunbog C., Olaussen R., Abrahamsen T., et al. Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects. Rev Front Neurol. [Internet] 2021 [Citado 27 Abr 2021]; 25(12): 20-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33716918/
González L. Roberto, Riquelme U. Alejandra, Fuentealba S. Mario, Canales Z. Jorge, Fuentes E. Alberto, Saldías F. René et al . Miastenia gravis: resultados inmediatos y alejados de la timectomía transesternal extendida. Rev. méd. Chile [Internet]. 2018 [Citado 16 Abr 2021] ; 146( 4 ): 460-469. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000400460&lang=es
Cortés E, Gallardo E, Álvarez R, et al. Myasthenia Gravis Treatment Updates. Curr Treat Options Neurol [Internet]. 2020 [citado 13-04-2021]; 22(24).Disponible en: https://link.springer.com/article/10.1007/s11940-020-00632-6
Cataneo A, Gilmar F, Cataneo, D. Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis. Orphanet J Rare Dis [Internet]. 2018[citado 13-04-2021];13(99). Disponible en:https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0837-z
Singh N, Goyal V. Timectomía en la miastenia grave no timomatosa: ¿Un ECA resuelve la controversia de 75 años?. Rev. Ann Indian Acad Neurol. [Internet] 2020 [Citado 16 Abr 2021]; 23 (1): 10-12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001447/
Chang T. Evidence and controversy for thymectomy in myasthenia gravis.Chinese journal of neurology [Internet]. 2020[citado 13 -04-2021];, 53(6), 405‐409. https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02160606/full
Wenxin T, Xiao Li, Hongfeng T, Wenhan W, (et al). Surgical effect and prognostic factors of myasthenia gravis with thymomas. Thoracic Cancer [Internet].2020 [15 de Abril del 2021]; 11(5):1288–1296. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/1759-7714.13396
Padina N, Martinez D, Sanchez A. Descripción de las características clínicas y la respuesta a tratamiento en pacientes con miastenia grave sin timoma sometidos a timectomía en una institución de alta complejidad de Cali, Colombia, 20102017.Revista Colombiana de Cirugia Internet].2020[citado 13 -04-2021]; 35(3): 391397. Disponible en: https://www.redalyc.org/jatsRepo/3555/355566075008/index.html
Arce-Aranda C., Lee C., Torrent M. A., Leiva A., Flor R., Soskin Reidman A., et al. Timectomía Videotoracoscopica Para El Tratamiento De La Miastenia Gravis. Rev. Cir. Parag. [Internet]. 2019 [Citado 15 Abr 2021]; 43(1): 27-31. Disponible en: http://scielo.iics.una.py//scielo.php?script=sci_arttext&pid=S230704202019000100027&lang=es
Ambrogi V, Tacconi F, Sellitri F, Tamburrini A, Perroni G, Carlea, F, Mineo, T. Subxiphoid completion thymectomy for refractory non-thymomatous myasthenia gravis. Journal of Thoracic Disease [Internet]. 2020 [citado 13 -04-2021]; 12(5), 2388– 2394. Disponible en: https://jtd.amegroups.com/article/view/38676/html
Cabrera-Maqueda J.M., Alba Isasi M. T., Hernández R., Arroyo-Tristán A., MoralesOrtiz A. Timectomia en Miastenia Gravis Timomatosa y No Timomatosa: Análisis de una cohorte de 46 pacientes. Rev. Neurol. [Internet] 2020 [Citado 20 Abr 2021]; 70(6): 5 pags aprox. Disponible en: https://neurologia.com/articulo/2019411
Agüero A., Farina C., Zelada I., Chong L., Galeano M. Manejo Quirúrgico de la Miastenia Gravis. Cir. Párr. [Internet]. 2019 [Citado 15 Abr 2021]; 43(2)
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Jessica Ximena Humala Rojas, Susan Karina Ortega Castillo, Sandra Marisol Yumbla González
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. Since Prometeo Journal is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
